Strix Group very well positioned to maximise opportunities (LON:KETL)
28 September 2022
CareDx, Inc. (CDNA) is a key player in the healthcare sector, specializing in diagnostics and research aimed at improving outcomes for transplant patients. Headquartered in Brisbane, California, CareDx provides a..
Immunome, Inc. (NASDAQ: IMNM) is capturing investor attention with its impressive potential upside of 62.72%, according to recent analyst ratings. With a focus on developing innovative treatments for cancer through..
Investors with a keen eye on the biotechnology sector might find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) a compelling addition to their portfolios. With a market cap of $1.41 billion, this..
Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning player in the biotechnology sector, is drawing significant attention from investors, driven largely by its impressive 21.29% potential upside based on current analyst..
Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor attention with its innovative approach to cancer treatment and a compelling potential upside of over 121%. Specializing in medical devices within the..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a biotechnology firm focused on developing treatments for chronic cough conditions, presents a compelling investment opportunity with an impressive potential upside of 80.45%. Situated within..
For investors with an eye on the healthcare sector, Zymeworks Inc. (NASDAQ: ZYME) presents a compelling opportunity within the biotechnology industry. Based in Middletown, Delaware, Zymeworks is making waves with..
Investors seeking opportunities in the healthcare sector might find Vir Biotechnology, Inc. (NASDAQ: VIR) an intriguing candidate, particularly given its robust analyst ratings and significant potential upside. As a clinical-stage..
Enliven Therapeutics, Inc. (NASDAQ: ELVN) has been capturing significant attention in the biotechnology sector, with analysts unanimously rating it as a “Buy.” As a clinical-stage biopharmaceutical company, Enliven is focused..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company headquartered in Langhorne, Pennsylvania, is capturing the attention of investors with its promising pipeline in the treatment of rare respiratory diseases. With..
Avadel Pharmaceuticals plc (NASDAQ: AVDL), a biopharmaceutical company based in Dublin, Ireland, has been capturing investor attention with its robust revenue growth of 54.90%. Specializing in the development of specialty..
Replimune Group, Inc. (NASDAQ: REPL) is making waves in the biotechnology sector with its innovative approach to cancer treatment and significant upside potential. This clinical-stage company, headquartered in Woburn, Massachusetts,..
Investors with a keen eye on the biotechnology sector may find uniQure N.V. (NASDAQ: QURE) an intriguing prospect, especially given its remarkable potential upside of 120.27%. Based in Amsterdam, Netherlands,..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biopharmaceutical sector, is capturing investor attention with its promising pipeline of cancer therapies. Headquartered in New York, this biotechnology firm..
For investors seeking opportunities in the biotechnology sector, CorMedix Inc. (CRMD) offers a compelling case. With a potential upside of 106.69%, the stock has garnered attention due to its promising..
Oculis Holding AG (OCS), a promising player in the biotechnology sector, is garnering attention, particularly for its groundbreaking work in ophthalmic and neuro-ophthalmic treatments. With its headquarters in Zug, Switzerland,..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its impressive potential upside of 84.48%, based on the current average analyst target price of $11.14. This..
Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical device company based in Irvine, California, Beta..
LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biotechnology sector, is capturing investor interest with its innovative focus on vision-improving therapies and a remarkable potential upside. Headquartered in..
